New studies refine the apomorphine vs ropinirole choice

CURRENT BRIEF VERSION: A new head-to-head evidence base is sharpening the apomorphine-versus-ropinirole debate in canine emesis. Two 2025 studies reached slightly different conclusions depending on the setting: a blinded randomized crossover trial in healthy dogs found ophthalmic ropinirole and IV apomorphine had similarly high emesis success rates, though apomorphine worked faster, with median onset of 1.18 minutes versus 8.85 minutes for ropinirole. But a separate prospective randomized emergency-department study at 2 specialty hospitals, involving 132 client-owned dogs with suspected toxin or foreign-body ingestion, reported lower first-dose success, slower onset, more minor adverse events, and more protracted vomiting with ropinirole, concluding apomorphine was clinically superior for rapid decontamination. Ropinirole remains the only FDA-approved emetic for dogs in the U.S., marketed as Clevor since its 2020 approval, while apomorphine is still widely used extra-label. (frontiersin.org)

Why it matters: For veterinary teams, the choice may come down to speed, workflow, and patient selection. Apomorphine’s faster onset may matter most in toxin ingestions where every minute counts, while ropinirole offers an approved, ophthalmic option that can avoid injectable handling and has established label guidance. The tradeoff is that ropinirole has been associated with ocular irritation and longer vomiting in some dogs, which could complicate follow-up care such as oral therapies after decontamination. In the ER study, dogs that failed to vomit within 20 minutes received a second identical dose and were monitored for 40 minutes, underscoring how real-world protocol timing can affect workflow and rescue-treatment decisions. (frontiersin.org)

What to watch: Expect more discussion around which patients are best suited for each drug, especially as additional real-world studies evaluate ropinirole in clinical toxicology and emergency cases and look more closely at first-dose performance, repeat dosing, and need for antiemetic rescue. (frontiersin.org)